vs
Side-by-side financial comparison of IRONWOOD PHARMACEUTICALS INC (IRWD) and MetroCity Bankshares, Inc. (MCBS). Click either name above to swap in a different company.
IRONWOOD PHARMACEUTICALS INC is the larger business by last-quarter revenue ($47.7M vs $43.7M, roughly 1.1× MetroCity Bankshares, Inc.). MetroCity Bankshares, Inc. runs the higher net margin — 50.5% vs -4.8%, a 55.3% gap on every dollar of revenue. On growth, MetroCity Bankshares, Inc. posted the faster year-over-year revenue change (23.6% vs -47.3%). IRONWOOD PHARMACEUTICALS INC produced more free cash flow last quarter ($74.6M vs $37.0M). Over the past eight quarters, MetroCity Bankshares, Inc.'s revenue compounded faster (15.7% CAGR vs -20.2%).
Ironwood Pharmaceuticals, Inc. is a publicly traded pharmaceutical company. It was originally called Microbia, Inc.
Metro City Bank is a Korean-American bank based in Doraville, Georgia and offers personal and commercial banking services. It is the largest Korean-American bank to not be based out of Los Angeles, California. It currently operates a total of 19 branches in Texas, New York, New Jersey, Virginia, Georgia, Alabama, and Florida.
IRWD vs MCBS — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $47.7M | $43.7M |
| Net Profit | $-2.3M | $18.1M |
| Gross Margin | — | — |
| Operating Margin | 14.3% | 52.8% |
| Net Margin | -4.8% | 50.5% |
| Revenue YoY | -47.3% | 23.6% |
| Net Profit YoY | -200.9% | 11.7% |
| EPS (diluted) | $0.01 | $0.69 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $47.7M | $43.7M | ||
| Q3 25 | $122.1M | $38.0M | ||
| Q2 25 | $85.2M | $37.9M | ||
| Q1 25 | $41.1M | $36.0M | ||
| Q4 24 | $90.5M | $35.4M | ||
| Q3 24 | $91.6M | $36.9M | ||
| Q2 24 | $94.4M | $36.3M | ||
| Q1 24 | $74.9M | $32.7M |
| Q4 25 | $-2.3M | $18.1M | ||
| Q3 25 | $40.1M | $17.3M | ||
| Q2 25 | $23.6M | $16.8M | ||
| Q1 25 | $-37.4M | $16.3M | ||
| Q4 24 | $2.3M | $16.2M | ||
| Q3 24 | $3.6M | $16.7M | ||
| Q2 24 | $-860.0K | $16.9M | ||
| Q1 24 | $-4.2M | $14.6M |
| Q4 25 | 14.3% | 52.8% | ||
| Q3 25 | 61.8% | 62.8% | ||
| Q2 25 | 53.2% | 62.4% | ||
| Q1 25 | -70.7% | 61.3% | ||
| Q4 24 | 34.8% | 58.9% | ||
| Q3 24 | 28.0% | 61.4% | ||
| Q2 24 | 26.5% | 64.4% | ||
| Q1 24 | 14.7% | 62.6% |
| Q4 25 | -4.8% | 50.5% | ||
| Q3 25 | 32.8% | 45.5% | ||
| Q2 25 | 27.7% | 44.4% | ||
| Q1 25 | -90.9% | 45.3% | ||
| Q4 24 | 2.5% | 54.0% | ||
| Q3 24 | 4.0% | 45.3% | ||
| Q2 24 | -0.9% | 46.7% | ||
| Q1 24 | -5.6% | 44.8% |
| Q4 25 | $0.01 | $0.69 | ||
| Q3 25 | $0.23 | $0.67 | ||
| Q2 25 | $0.14 | $0.65 | ||
| Q1 25 | $-0.23 | $0.63 | ||
| Q4 24 | $0.03 | $0.64 | ||
| Q3 24 | $0.02 | $0.65 | ||
| Q2 24 | $-0.01 | $0.66 | ||
| Q1 24 | $-0.03 | $0.57 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $215.5M | $383.7M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $-261.8M | $544.2M |
| Total Assets | $396.9M | $4.8B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $215.5M | $383.7M | ||
| Q3 25 | $140.4M | $227.2M | ||
| Q2 25 | $92.9M | $286.0M | ||
| Q1 25 | $108.5M | $285.1M | ||
| Q4 24 | $88.6M | $249.9M | ||
| Q3 24 | $88.2M | $291.2M | ||
| Q2 24 | $105.5M | $327.9M | ||
| Q1 24 | $121.5M | $258.8M |
| Q4 25 | — | — | ||
| Q3 25 | $199.5M | — | ||
| Q2 25 | $199.3M | — | ||
| Q1 25 | $199.2M | — | ||
| Q4 24 | $199.0M | — | ||
| Q3 24 | $198.8M | — | ||
| Q2 24 | $198.6M | — | ||
| Q1 24 | $398.3M | — |
| Q4 25 | $-261.8M | $544.2M | ||
| Q3 25 | $-264.2M | $445.9M | ||
| Q2 25 | $-308.2M | $436.1M | ||
| Q1 25 | $-334.1M | $428.0M | ||
| Q4 24 | $-301.3M | $421.4M | ||
| Q3 24 | $-311.3M | $407.2M | ||
| Q2 24 | $-321.7M | $407.2M | ||
| Q1 24 | $-330.5M | $396.6M |
| Q4 25 | $396.9M | $4.8B | ||
| Q3 25 | $396.1M | $3.6B | ||
| Q2 25 | $342.9M | $3.6B | ||
| Q1 25 | $327.2M | $3.7B | ||
| Q4 24 | $350.9M | $3.6B | ||
| Q3 24 | $389.5M | $3.6B | ||
| Q2 24 | $395.6M | $3.6B | ||
| Q1 24 | $438.8M | $3.6B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $74.6M | $37.7M |
| Free Cash FlowOCF − Capex | $74.6M | $37.0M |
| FCF MarginFCF / Revenue | 156.3% | 84.7% |
| Capex IntensityCapex / Revenue | 0.0% | 1.5% |
| Cash ConversionOCF / Net Profit | — | 2.08× |
| TTM Free Cash FlowTrailing 4 quarters | $127.0M | $79.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $74.6M | $37.7M | ||
| Q3 25 | $47.6M | $16.5M | ||
| Q2 25 | $-15.1M | $14.5M | ||
| Q1 25 | $20.0M | $11.9M | ||
| Q4 24 | $15.2M | $63.5M | ||
| Q3 24 | $9.9M | $-11.5M | ||
| Q2 24 | $33.5M | $19.4M | ||
| Q1 24 | $45.0M | $36.4M |
| Q4 25 | $74.6M | $37.0M | ||
| Q3 25 | $47.6M | $16.2M | ||
| Q2 25 | $-15.1M | $14.3M | ||
| Q1 25 | $19.9M | $11.8M | ||
| Q4 24 | — | $62.2M | ||
| Q3 24 | $9.9M | $-11.8M | ||
| Q2 24 | $33.4M | $19.0M | ||
| Q1 24 | $44.9M | $36.1M |
| Q4 25 | 156.3% | 84.7% | ||
| Q3 25 | 39.0% | 42.7% | ||
| Q2 25 | -17.7% | 37.8% | ||
| Q1 25 | 48.4% | 32.9% | ||
| Q4 24 | — | 175.8% | ||
| Q3 24 | 10.8% | -31.9% | ||
| Q2 24 | 35.4% | 52.4% | ||
| Q1 24 | 60.0% | 110.6% |
| Q4 25 | 0.0% | 1.5% | ||
| Q3 25 | 0.0% | 0.7% | ||
| Q2 25 | 0.0% | 0.3% | ||
| Q1 25 | 0.1% | 0.2% | ||
| Q4 24 | 0.0% | 3.6% | ||
| Q3 24 | 0.0% | 0.8% | ||
| Q2 24 | 0.1% | 1.0% | ||
| Q1 24 | 0.1% | 0.7% |
| Q4 25 | — | 2.08× | ||
| Q3 25 | 1.19× | 0.95× | ||
| Q2 25 | -0.64× | 0.86× | ||
| Q1 25 | — | 0.73× | ||
| Q4 24 | 6.74× | 3.91× | ||
| Q3 24 | 2.71× | -0.69× | ||
| Q2 24 | — | 1.14× | ||
| Q1 24 | — | 2.49× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
